Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Some organic weak bases induce a detachment from inner lysosomal membranes and subsequent inactivation of acid sphingomyelinase (ASM) and thus work as functional ASM inhibitors. The aim of the present investigation was to develop a structure-property-activity relation (SPAR) model in order to specify the structural and physicochemical characteristics of probes capable of functionally inhibiting ASM. High p K a and high log P values are necessary but not sufficient preconditions for functional inhibition of ASM. The experimental data supported the requirement of an additional factor, which is necessary for functional inhibition of ASM. This factor k is related to the steric hindrance of the most basic nitrogen atom and presumably modulates the free presentation of a protonated nitrogen atom at the inner lysosomal surface. During the course of the study, we characterized 26 new functional ASM inhibitors, including doxepine 63, fluoxetine 104, maprotiline 109, nortriptyline 114, paroxetine 118, sertraline 124, suloctidil 125, and terfenadine 127.
Kornhuber
Johannes
J
Department of Psychiatry and Psychotherapy, University of Erlangen, Germany. Johannes.Kornhuber@uk-erlangen.de
Tripal
Philipp
P
Reichel
Martin
M
Terfloth
Lothar
L
Bleich
Stefan
S
Wiltfang
Jens
J
Gulbins
Erich
E
D000465:Algorithms; D000818:Animals; D002460:Cell Line; D045744:Cell Line, Tumor; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004791:Enzyme Inhibitors / Q000737:chemistry* / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008968:Molecular Conformation; D021281:Quantitative Structure-Activity Relationship; D051381:Rats; D013108:Sphingomyelin Phosphodiesterase / Q000037:antagonists & inhibitors* / Q000737:chemistry*
D004791:Enzyme Inhibitors; D013108:Sphingomyelin Phosphodiesterase